These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1216 related items for PubMed ID: 17283286

  • 1. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC.
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [Abstract] [Full Text] [Related]

  • 2. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
    Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS.
    Biol Psychiatry; 2005 Dec 15; 58(12):969-73. PubMed ID: 16043137
    [Abstract] [Full Text] [Related]

  • 3. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.
    Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, Schnepf B, Boeker H, Boesiger P, Northoff G.
    Arch Gen Psychiatry; 2009 May 15; 66(5):478-86. PubMed ID: 19414707
    [Abstract] [Full Text] [Related]

  • 4. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
    Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC.
    Arch Gen Psychiatry; 2012 May 15; 69(5):449-59. PubMed ID: 22213769
    [Abstract] [Full Text] [Related]

  • 5. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A, Ankerst DP.
    Psychiatry Res; 2006 Jun 30; 147(1):1-25. PubMed ID: 16806850
    [Abstract] [Full Text] [Related]

  • 6. The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.
    Murck H, Schubert MI, Schmid D, Schüssler P, Steiger A, Auer DP.
    J Psychiatr Res; 2009 Jan 30; 43(3):175-80. PubMed ID: 18533184
    [Abstract] [Full Text] [Related]

  • 7. Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study.
    Nery FG, Stanley JA, Chen HH, Hatch JP, Nicoletti MA, Monkul ES, Matsuo K, Caetano SC, Peluso MA, Najt P, Soares JC.
    Psychiatry Res; 2009 Dec 30; 174(3):177-83. PubMed ID: 19910168
    [Abstract] [Full Text] [Related]

  • 8. Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.
    Zhang X, Tang Y, Maletic-Savatic M, Sheng J, Zhang X, Zhu Y, Zhang T, Wang J, Tong S, Wang J, Li Y.
    J Affect Disord; 2016 Sep 01; 201():153-61. PubMed ID: 27235818
    [Abstract] [Full Text] [Related]

  • 9. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
    Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF.
    Arch Gen Psychiatry; 2004 Jul 01; 61(7):705-13. PubMed ID: 15237082
    [Abstract] [Full Text] [Related]

  • 10. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
    Godfrey KEM, Gardner AC, Kwon S, Chea W, Muthukumaraswamy SD.
    J Psychiatr Res; 2018 Oct 01; 105():33-44. PubMed ID: 30144668
    [Abstract] [Full Text] [Related]

  • 11. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.
    Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P.
    Biol Psychiatry; 2005 Nov 01; 58(9):700-4. PubMed ID: 16084860
    [Abstract] [Full Text] [Related]

  • 12. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
    Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF.
    Biol Psychiatry; 2004 Sep 01; 56(5):340-8. PubMed ID: 15336516
    [Abstract] [Full Text] [Related]

  • 13. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.
    Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, Ryan CM, Kim JE, Renshaw PF, Jacobson AM.
    Arch Gen Psychiatry; 2009 Aug 01; 66(8):878-87. PubMed ID: 19652127
    [Abstract] [Full Text] [Related]

  • 14. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ, Mao X, Banerjee S, Goodman Z, Lapidus KA, Kang G, Liston C, Shungu DC.
    J Psychiatry Neurosci; 2016 Apr 01; 41(3):E37-45. PubMed ID: 26900793
    [Abstract] [Full Text] [Related]

  • 15. Decreased prefrontal Myo-inositol in major depressive disorder.
    Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS.
    Biol Psychiatry; 2005 Jun 15; 57(12):1526-34. PubMed ID: 15953489
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy.
    Ritter C, Buchmann A, Müller ST, Volleberg M, Haynes M, Ghisleni C, Noeske R, Tuura R, Hasler G.
    JAMA Psychiatry; 2022 Dec 01; 79(12):1209-1216. PubMed ID: 36260322
    [Abstract] [Full Text] [Related]

  • 17. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients.
    Caetano SC, Fonseca M, Olvera RL, Nicoletti M, Hatch JP, Stanley JA, Hunter K, Lafer B, Pliszka SR, Soares JC.
    Neurosci Lett; 2005 Aug 26; 384(3):321-6. PubMed ID: 15936878
    [Abstract] [Full Text] [Related]

  • 18. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
    Salvadore G, van der Veen JW, Zhang Y, Marenco S, Machado-Vieira R, Baumann J, Ibrahim LA, Luckenbaugh DA, Shen J, Drevets WC, Zarate CA.
    Int J Neuropsychopharmacol; 2012 Sep 26; 15(8):1063-72. PubMed ID: 22040773
    [Abstract] [Full Text] [Related]

  • 19. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS, Rashid R, Dong Z, Kegeles LS, Grunebaum MF, Ogden RT, Lin X, Mulhern ST, Suckow RF, Cooper TB, Keilp JG, Mao X, Shungu DC, Mann JJ.
    JAMA Netw Open; 2020 Aug 03; 3(8):e2013211. PubMed ID: 32785636
    [Abstract] [Full Text] [Related]

  • 20. Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder.
    Michael N, Erfurth A, Pfleiderer B.
    Psychiatry Res; 2009 Apr 30; 172(1):78-81. PubMed ID: 19239983
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 61.